Francisco M. Marty, Lisa A. Cosimi, Lindsey Robert Baden
Abstract
Open-access reader
To the Editor: The Food and Drug Administration (FDA) approved voriconazole for the treatment of invasive aspergillosis partly on the basis of data published in a report in the Journal, 1 which sho...
OpenAlex reports 426 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To the Editor: The Food and Drug Administration (FDA) approved voriconazole for the treatment of invasive aspergillosis partly on the basis of data published in a report in the Journal, 1 which sho...
Key concepts: Voriconazole, Medicine, Zygomycosis, Aspergillosis, Food and drug administration, Hematopoietic stem cell transplantation, Amphotericin B, Hematopoietic stem cell